|
Markets with Scale ScaleVP has built a track record of successful companies and top quartile financial performance with a consistent strategy driven by our market insights. We're active investors. We lead new rounds and use our board seats to drive growth. Our initial investment can range from $5M to $15M, depending on your need. We keep capital in reserve for our companies, so our investment dollars can scale with your growth. In both technology and healthcare, Scale Venture Partners targets a handful of market themes -- emerging customer needs or technology capabilities -- that drive strong secular growth across multiple specific markets for years to come. Our focus brings you understanding and insight based on our real-world experience in related markets. For example, we've invested in a series of successful software-as-a-service companies since 1999 that have created many billions of dollars of market value. Within these themes, we examine specific market opportunities, emphasizing primary research with incumbents and startups, customers, and the larger ecosystem. Often, our best investments are companies we proactively contacted. The investment insights and networks developed from our market assessments show us where, when and how to drive scale. |
Tech Markets With Scale We're actively pursuing investments in several areas where technology shifts are causing spectacular secular growth. Consumers are changing how and where they consume media, creating opportunities in hardware, software, services and content. Marketers must reach their customers in those new venues and with new voices. The value chain for creating electronic devices has exploded and reassembled with new players. Businesses have to adapt to new technical challenges and manage the ensuing chaos, creating opportunity for software-as-a-service and data center software and systems. Pivotal ScaleVP companies:
Healthcare Markets With Scale ScaleVP knows which business models work in healthcare. We had early insight into the shift from unproven compounds to drugs with known human safety and efficacy. We have aggressively pursued investments where innovation, combinations with new delivery methods, and reduced risk allow access to large markets. The aging population and explosion of obesity, diabetes and related conditions create numerous investment opportunities, both in drugs as well as in devices and services. Pivotal ScaleVP companies: |
